Dynavax Technologies Corporation (Nasdaq: DVAX) entered into a research collaboration and license agreement with AstraZeneca (NYSE: AZN) for the discovery ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE